000 | 01602 a2200421 4500 | ||
---|---|---|---|
005 | 20250514042025.0 | ||
264 | 0 | _c20021007 | |
008 | 200210s 0 0 fre d | ||
022 | _a0399-8320 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDuclos-Vallée, Jean-Charles | |
245 | 0 | 0 |
_a[Treatment of hepatitis C virus associated extrahepatic manifestations]. _h[electronic resource] |
260 |
_bGastroenterologie clinique et biologique _cApr 2002 |
||
300 |
_aB76-81 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Consensus Development Conference; Journal Article; Review | ||
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aAutoantibodies _ximmunology |
650 | 0 | 4 | _aClinical Enzyme Tests |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCryoglobulinemia _xetiology |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xetiology |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferons _xadministration & dosage |
650 | 0 | 4 |
_aLichen Planus _xetiology |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xetiology |
650 | 0 | 4 |
_aPorphyria Cutanea Tarda _xetiology |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPurpura, Thrombocytopenic _xetiology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 |
_aSjogren's Syndrome _xetiology |
650 | 0 | 4 |
_aThyroid Diseases _xetiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransaminases _xblood |
773 | 0 |
_tGastroenterologie clinique et biologique _gvol. 26 Spec No 2 _gp. B76-81 |
|
999 |
_c12062811 _d12062811 |